Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Re:NewCell on its IPO
Mandate

Vinge advises Re:NewCell on its IPO

November 27, 2020 Banking and Finance M&A Corporate Tax Capital Markets and Public M&A

Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Market.

The company is the first in the world to commercially offer a dissolving pulp for textile production manufactured from 100 per cent recycled textiles.

The Vinge team includes Christian Lindhé, Erik Sjöman, Ludvig Frithiof and Nora Gullberg (Capital Markets and Public M&A), Henrik Ossborn and Jack Bengtsson (Banking and Finance), Anna Edström and Martin Svanberg (M&A) as well as Maria Schultzberg (Tax).

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026